In Vitro Exposure of Treponema pallidum to Subbactericidal Doxycycline Did Not Induce Resistance: Implications for Doxycycline Postexposure Prophylaxis
The Journal of Infectious Diseases · 17.03.2025 · 231 (3) · 729-733
DOI: 10.1093/infdis/jiae381 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 27.07.2024. Verfasst von Lauren C Tantalo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Doxycycline, Anti-Bacterial Agents, Drug Resistance, Bacterial, Treponema pallidum. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Doxycycline postexposure prophylaxis (doxy-PEP) could significantly reduce syphilis incidence. However, the increase in intermittent doxycycline usage might select resistant Treponema pallidum strains. To assess whether resistance to doxycycline could be induced in this pathogen, we exposed the SS14 strain in vitro, both intermittently and continuously, to a subbactericidal doxycycline concentration that still exerts antibiotic pressure. During and after each exposure experiment, we assessed the doxycycline minimal inhibitory concentration in test and control treponemes and performed whole-genome sequencing, concluding that no resistance developed. This work suggests that doxycycline-resistant T. pallidum is not an immediate threat for doxy-PEP implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, Washington, USA.
- Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
- Department of Global Health, University of Washington, Seattle, Washington, USA.
- Department of Epidemiology, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Lorenzo Giacani
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Tantalo, L. C., Luetkemeyer, A. F., Lieberman, N. A. P., Nunley, B. E., Avendaño, C., Greninger, A. L., Celum, C., & Giacani, L. (2025). In Vitro Exposure of Treponema pallidum to Subbactericidal Doxycycline Did Not Induce Resistance: Implications for Doxycycline Postexposure Prophylaxis. The Journal of Infectious Diseases, 231(3), 729-733. https://doi.org/10.1093/infdis/jiae381
Vancouver
Tantalo LC, Luetkemeyer AF, Lieberman NAP, Nunley BE, Avendaño C, Greninger AL, et al. In Vitro Exposure of Treponema pallidum to Subbactericidal Doxycycline Did Not Induce Resistance: Implications for Doxycycline Postexposure Prophylaxis. The Journal of Infectious Diseases. 2025;231(3):729-733. doi:10.1093/infdis/jiae381
BibTeX
@article{Tantalo2025,
author = {Tantalo, Lauren C and Luetkemeyer, Anne F and Lieberman, Nicole A P and Nunley, B Ethan and Avendaño, Carlos and Greninger, Alexander L and Celum, Connie and Giacani, Lorenzo},
title = {In Vitro Exposure of Treponema pallidum to Subbactericidal Doxycycline Did Not Induce Resistance: Implications for Doxycycline Postexposure Prophylaxis},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {231},
number = {3},
pages = {729--733},
doi = {10.1093/infdis/jiae381}
}
EUVIMED